← Back
$DNTH All transactions

Dianthus Therapeutics, Inc. /DE/

▼ SELL 10b5-1 Plan

$ Value

$26K

Shares

300

Price

$86

Filed

Mar 13

Insider

Name

CARR EDWARD

Title

CHIEF ACCOUNTING OFFICER

CIK

0001273351

Roles

Officer

Transaction Details

Transaction Date

2026-03-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.30 to $81.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.30 to $82.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.34 to $83.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001273351-26-000004

Form Type

4

Issuer CIK

0001690585

CARR EDWARD's History

Date Ticker Type Value
2026-03-12 DNTH M $289K
2026-03-12 DNTH M $386K
2026-03-12 DNTH M $218K
2026-03-12 DNTH $1.3M
2026-03-12 DNTH $1.9M
2026-03-12 DNTH $319K
2026-03-12 DNTH $17K
2026-03-12 DNTH $26K
2026-03-12 DNTH M $0
2026-03-12 DNTH M $0

Other Insiders at DNTH (90d)

Insider Bought Sold Last
CARR EDWARD
CHIEF ACCOUNTING OFFICER
$3.5M 2026-03-12
Garcia Marino
CEO AND PRESIDENT
$10.0M 2026-03-16
Soteropoulos Paula $2.2M 2026-03-31
Veness Adam M
SVP, General Counsel and Sec.
2026-02-03
Randhawa Simrat
EVP, Head of R&D
$2.8M 2026-03-12
Savitz Ryan
EVP, CFO & CBO
$10.2M 2026-04-09